Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Adjuvant hormonal therapy for premenopausal women with breast cancer.

Adjuvant hormonal therapy for premenopausal women with breast cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Adjuvant hormonal therapy for premenopausal women with breast cancer. Abstract Text:

    regina j brownRegina J Brown,nancy e davidsonNancy E Davidson,

    Endocrine therapy is a required element of the management of premenopausal women with early-stage steroid hormone receptor-positive breast cancer. There is uncertainty about how best to implement that therapy using the strategies of tamoxifen and estrogen deprivation as well as how to integrate these approaches with chemotherapy. Other research focuses on identification of improved markers for endocrine response or resistance and on the special side effects of endocrine therapy in young women.

    Adjuvant hormonal therapy for premenopausal women with breast cancer. Publishing Authors By Initials

    rj brownRJ Brown,ne davidsonNE Davidson,

    For similar biological factors: biological markers: tumor markers, biological research abstracts see: biological factors: biological markers: tumor markers, biological research

    PUBMED ID PMID:

    MEDLINE DATE:

    Adjuvant hormonal therapy for premenopausal women with breast cancer. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Seminars in oncology

    VOLUME: 33

    Page Numbers: 657-63

    Journal Abbreviation: Semin. Oncol.

    ISSN: 0093-7754

    DAY: 3

    MONTH: Dec

    YEAR: 2006

    Adjuvant hormonal therapy for premenopausal women with breast cancer. Information

    Number of References: 37

    LANGUAGE: eng

    NlmUniqueID: 420432

    Adjuvant hormonal therapy for premenopausal women with breast cancer. Keywords Mesh Terms:

    KEYWORDS: Tumor Markers, Biological

    MESH TERMS: analysis

    Chemical & Substance for Abstract: Adjuvant hormonal therapy for premenopausal women with breast cancer. Information

    Substance Name: Tamoxifen

    Registry Number: 10540-29-1

    Grant and Affiliation Information for Adjuvant hormonal therapy for premenopausal women with breast cancer.

    AFFILIATION: Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231-1000, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: CA88843

    ACRONYM: CA

    MEDLINETA: Semin Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Adjuvant hormonal therapy for premenopausal women with breast cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News